Major Declarations Stocks: Actavis plc (NYSE:ACT), Pfizer Inc. (NYSE:PFE), Northrop Grumman Corporation (NYSE:NOC)

Actavis plc (NYSE:ACT) Trend Analysis declared that it has successfully complete its tender propose to buy all outstanding shares of Durata Therapeutics (DRTX), a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses. Actavis plc (NYSE:ACT) stock price closed at $247.94 with the total traded volume of 16.7 Million shares. Its price to sales ratio ended at 5.58. Its market capitalization is 65.719 Billion. The stock owned by the Financial Institutions was 78.00% while by insiders was 0.10%.Portola Pharma, Bristol-Myers Squibb (BMY) and Pfizer Inc. (NYSE:PFE) Trend Analysis reported that statistically significant results from the first part of the Phase 3 ANNEXA-A studies of investigational andexanet alfa with eliquis; produced rapid and nearly complete reversal. The examination included 33 subjects, with 24 randomized to andexanet alfa and nine to placebo. Pfizer Inc. (NYSE:PFE) begun last trade with a price of $29.91 and throughout the trading session climbed at a high of $30.41. The day-trade ended with -0.07% to $30.32. The stock is going forward to its 52 week low with 11.18% and lagging behind from its 52 week high price with -5.57%. PFE last month stock price volatility remained 1.41%.Northrop Grumman Corporation (NYSE:NOC) Trend Analysis released that it has been awarded a agreement from Naval Air Systems Command to deliver its next-generation mission computer for the Marine Corps' H-1 helicopter upgrade program. Northrop Grumman Corporation (NYSE:NOC) has the market capitalization of 27.454 Billion. Shares of firm plunged -0.12% to close at $135.91 with the total traded volume of 768782. The firm has current ratio of 1.50 for the most recent quarter.